mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0006 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |